EUVIMEDEUVIMED entdecken
Open Access

The Intersection of Atrial Fibrillation and Coronary Artery Disease in Middle Eastern Patients. Analysis from the Jordan Atrial Fibrillation Study

Ayman Hammoudeh iD, Yahya Badaineh, Ramzi Tabbalat iD, Anas Ahmad, Mohammad Bahhour, Darya Ja'ara, Joud Shehadeh, Mohammad A Jum'ah, Afnan Migdad, Mohammad Hani, Imad A Alhaddad iD

Global Heart · 12.03.2024 · 19 (1)

DOI: 10.5334/gh.1312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Heart, erschienen am 12.03.2024. Verfasst von Ayman Hammoudeh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Istishari Hospital, 44 Kindi Street, Amman 11954, Jordan. Hauptthemen laut MEDLINE: Coronary Artery Disease, Atrial Fibrillation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is a scarcity of clinical studies which evaluate the association of atrial fibrillation (AF) and coronary artery disease (CAD) in the Middle East. The aim of this study was to evaluate the impact of CAD on baseline clinical profiles and one-year outcomes in a Middle Eastern cohort with AF.

Methods

Consecutive AF patients evaluated in 29 hospitals and cardiology clinics were enrolled in the Jordan AF Study (May 2019-December 2020). Clinical and echocardiographic features, use of medications and one-year outcomes in patients with AF/CAD were compared to AF/no CAD patients.

Results

Of 2020 AF patients enrolled, 216 (10.7%) had CAD. Patients with AF/CAD were more likely to be men and had significantly higher prevalence of hypertension, diabetes, dyslipidemia, heart failure and chronic kidney disease compared to the AF/no CAD patients. They also had lower mean left ventricular ejection fraction and larger left atrial size. Mean CHA2DS2 VASc and HAS-BLED scores were higher in AF/CAD patients than those with AF/no CAD (4.3 ± 1.7 vs. 3.6 ± 1.8, p < 0.0001) and (2.0 ± 1.1 vs. 1.6 ± 1.1, p < 0.0001), respectively. Oral anticoagulant agents were used in similar rates in the two groups (83.8% vs. 82.9%, p = 0.81), but more patients with AF/CAD were prescribed additional antiplatelet agents compared to patients with AF/no CAD (73.7% vs. 41.5%, p < 0.0001). At one year, AF/CAD patients, compared to AF/no CAD patients had significantly higher hospitalization rate (39.4% vs. 29.2%, p = 0.003), more acute coronary syndrome and coronary revascularization (6.9% vs. 2.4%, p = 0.004), and higher all-cause mortality (18.5% vs. 10.9%, p = 0.002).

Conclusions

In this cohort of Middle Eastern patients with AF, one in 10 patients had CAD. The coexistence of AF and CAD was associated with a worse baseline clinical profile and one-year outcomes. Clinical study registration: the study is registered on clinicaltrials.gov (unique identifier number NCT03917992).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseAtrial FibrillationMaleHumansFemaleStroke VolumeJordanVentricular Function, LeftRisk Factors

Stichwörter der Autor:innen

Atrial fibrillationCoronary artery diseaseMiddle Eastern populationOral anticoagulant agentsPrognosis

Autor:innen und Institutionen

  • Department of Cardiology, Istishari Hospital, 44 Kindi Street, Amman 11954, Jordan.
  • Department of Cardiology, Abdali Hospital, 1 Istethmar Street/Abdali Boulevard, Amman 11190, Jordan.
  • Coronary Care Unit, Istishari Hospital, 44 Kindi Street, Amman 11954, Jordan.
  • Department of Internal Medicine, Istishari hospital, 44 Kindi Street, Amman 11954, Jordan.
  • Jordan Cardiovascular Center, Jordan Hospital, 4 Queen Rania Hospital, Amman, Jordan.

ORCID-Profile: Ayman Hammoudeh, Ramzi Tabbalat, Imad A Alhaddad

Zitieren

APA

Hammoudeh, A., Badaineh, Y., Tabbalat, R., Ahmad, A., Bahhour, M., Ja'ara, D., Shehadeh, J., Jum'ah, M. A., Migdad, A., Hani, M., & Alhaddad, I. A. (2024). The Intersection of Atrial Fibrillation and Coronary Artery Disease in Middle Eastern Patients. Analysis from the Jordan Atrial Fibrillation Study. Global Heart, 19(1). https://doi.org/10.5334/gh.1312

Vancouver

Hammoudeh A, Badaineh Y, Tabbalat R, Ahmad A, Bahhour M, Ja'ara D, et al. The Intersection of Atrial Fibrillation and Coronary Artery Disease in Middle Eastern Patients. Analysis from the Jordan Atrial Fibrillation Study. Global Heart. 2024;19(1). doi:10.5334/gh.1312

BibTeX
@article{Hammoudeh2024,
  author = {Hammoudeh, Ayman and Badaineh, Yahya and Tabbalat, Ramzi and Ahmad, Anas and Bahhour, Mohammad and Ja'ara, Darya and Shehadeh, Joud and Jum'ah, Mohammad A and Migdad, Afnan and Hani, Mohammad and Alhaddad, Imad A},
  title = {The Intersection of Atrial Fibrillation and Coronary Artery Disease in Middle Eastern Patients. Analysis from the Jordan Atrial Fibrillation Study},
  journal = {Global Heart},
  year = {2024},
  volume = {19},
  number = {1},
  doi = {10.5334/gh.1312}
}
Kostenlos starten →